USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases

by PVA_Admin | Oct 6, 2021 | 2021 Press Release, Press Release

USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI) and the Jerome Canady Research Institute for Advanced and Biological...

USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference

by PVA_Admin | Sep 9, 2021 | 2021 Press Release, Press Release

USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a U.S....

JCRI Discovers the Mechanism using Canady Helios™ Cold Plasma to Induce Cell Death in Breast Cancer

by PVA_Admin | Sep 2, 2021 | 2021 Press Release, Press Release

JCRI Discovers the Mechanism using Canady Helios™ Cold Plasma to Induce Cell Death in Breast Cancer TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS), in collaboration with...

USMI Developing the First Surgical Robot for Cancer Surgery

by PVA_Admin | May 5, 2021 | 2021 Press Release, Press Release

USMI Developing the First Surgical Robot for Cancer Surgery TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI) announced today that it is developing the first robotic delivery system used for cancer surgery. The new Canady Surgical System...

JCRI-ABTS and USMI Successfully Use Canady Helios™ Cold Plasma in Combination with FOLFIRINOX for the Treatment of Cholangiocarcinoma

by PVA_Admin | Apr 28, 2021 | 2021 Press Release, Press Release

JCRI-ABTS and USMI Successfully Use Canady Helios™ Cold Plasma in Combination with FOLFIRINOX for the Treatment of Cholangiocarcinoma TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological Sciences...

JCRI-ABTS and USMI Successfully Complete Phase 1 Multi-Center Clinical Trial Using Canady Helios™ Cold Plasma for the Treatment of Cancer

by PVA_Admin | Apr 20, 2021 | 2021 Press Release, Press Release

JCRI-ABTS and USMI Successfully Complete Phase 1 Multi-Center Clinical Trial Using Canady Helios™ Cold Plasma for the Treatment of Cancer TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological...